I thought we filed a woefully prepared IND with the FDA and it was insufficient to a very high degree.
I really do not care about some bush league experiments in Europe.
It is the FDA that matters.
Let's assume (and I am really reaching here) that in 10 years the FDA excepts PMCB's IND. They will then grant us a phase 1 trial and we will still be ten years from monetizing the treatment.
Gene editing companies will make this treatment akin to bleeding patients with leeches long before this ever becomes relevant which it won't. Why
Because our execs just want their portfolios padded with huge salaries before retirement and will do just enough to put out press releases to grab newbies. KW could not even describe the treatment on the BIG BIZ Show (terrible performance)